Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEE
1826
DELISTED
Sealed Air
SEE
| $2.69M | ﹤0.01% |
+72,400
| New | +$2.6M |
|
1827
CytomX Therapeutics
CTMX
$690M
| $2.69M | ﹤0.01% |
1,232,800
-92,900
| -7% | -$171K |
|
1828
Virtus Investment Partners
VRTS
$1.13B
| $2.69M | ﹤0.01% |
+10,829
| New | +$2.57M |
|
1829
Southern First Bancshares
SFST
$601M
| $2.68M | ﹤0.01% |
84,507
+4,000
| +5% | +$137K |
|
1830
Outfront Media
OUT
$5.61B
| $2.67M | ﹤0.01% |
+161,743
| New | +$2.28M |
|
1831
WisdomTree US LargeCap Dividend Fund
DLN
$6.3B
| $2.67M | ﹤0.01% |
37,000
+16,500
| +80% | +$1.13M |
|
1832
Ingevity
NGVT
$2.52B
| $2.66M | ﹤0.01% |
55,800
+42,400
| +316% | +$1.91M |
|
1833
Vera Bradley
VRA
$99.2M
| $2.66M | ﹤0.01% |
391,540
-47,300
| -11% | -$347K |
|
1834
DXP Enterprises
DXPE
$2.53B
| $2.65M | ﹤0.01% |
49,400
+5,200
| +12% | +$195K |
|
|
VERV
1835
DELISTED
Verve Therapeutics
VERV
| $2.65M | ﹤0.01% |
199,327
+34,760
| +21% | +$461K |
|
1836
United Microelectronic
UMC
$46.9B
| $2.64M | ﹤0.01% |
326,200
-2,319,650
| -88% | -$18.5M |
|
1837
Nurix Therapeutics
NRIX
$2.41B
| $2.64M | ﹤0.01% |
179,300
+64,100
| +56% | +$689K |
|
1838
Evolent Health
EVH
$353M
| $2.63M | ﹤0.01% |
+80,199
| New | +$2.56M |
|
1839
Invesco S&P 500 Quality ETF
SPHQ
$19.6B
| $2.63M | ﹤0.01% |
43,500
-40,400
| -48% | -$2.31M |
|
1840
LifeMD
LFMD
$180M
| $2.62M | ﹤0.01% |
255,100
+61,700
| +32% | +$456K |
|
1841
Green Dot
GDOT
$754M
| $2.62M | ﹤0.01% |
280,800
+195,078
| +228% | +$1.72M |
|
1842
AngloGold Ashanti
AU
$41.3B
| $2.62M | ﹤0.01% |
117,916
-575,700
| -83% | -$10.8M |
|
|
GAMB
1843
DELISTED
Gambling.com
GAMB
| $2.62M | ﹤0.01% |
286,800
+58,600
| +26% | +$532K |
|
1844
Movado Group
MOV
$866M
| $2.62M | ﹤0.01% |
93,698
+38,898
| +71% | +$1.09M |
|
|
PMT
1845
PennyMac Mortgage Investment
PMT
$823M
| $2.61M | ﹤0.01% |
178,000
+155,808
| +702% | +$2.23M |
|
1846
ALX Oncology
ALXO
$260M
| $2.61M | ﹤0.01% |
234,100
-36,400
| -13% | -$511K |
|
|
XRN
1847
Chiron Real Estate Inc
XRN
$467M
| $2.61M | ﹤0.01% |
59,620
+29,240
| +96% | +$1.4M |
|
1848
Immersion
IMMR
$248M
| $2.6M | ﹤0.01% |
347,700
-55,500
| -14% | -$395K |
|
1849
Air T
AIRT
$83.4M
| $2.6M | ﹤0.01% |
116,911
-1,100
| -0.9% | -$19.1K |
|
1850
Equitable Holdings
EQH
$13.1B
| $2.59M | ﹤0.01% |
+68,200
| New | +$2.32M |
|
Similar funds
Renaissance Technologies's Q1 2024 Portfolio in Review
As of Q1 2024, Renaissance Technologies held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Chevron worth $331M.
- Renaissance Technologies's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Renaissance Technologies added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Renaissance Technologies's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Renaissance Technologies fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Renaissance Technologies's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Renaissance Technologies opened 563 new positions and closed 582 in Q1 2024.
- Renaissance Technologies's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.